Clinical trials: Primary Immune-Deficiency (PID) Common Variable Immune Deficiency (CVID), open to volunteers
- Condition Primary Immune-Deficiency (PID) Common Variable Immune Deficiency (CVID)
- Status Open to volunteers
Primary Immunodeficiency Disease
IVIG Boya: Safety, Efficacy, and Pharmacokinetics
The goal of this phase 3, open-label, single-group clinical trial is to assess the efficacy of Boya IVIG in maintaining the mean number of serious bacterial infections to less than one per year in participants with primary…
- Trial name
- BoyaIVIG (NCT06150833)
- Testing
- Boya IVIG
- Volunteers
- 50 people
- Sponsor
- Azidus Brasil